Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-25-000022
Filing Date
2025-07-31
Accepted
2025-07-31 11:33:08
Documents
121
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K sny-20250630.htm   iXBRL 6-K 348402
2 EX-99.1 sny-20250630_d2.htm   iXBRL EX-99.1 1549793
3 EX-99.2 exhibit992-2025halfyearman.htm EX-99.2 714154
10 a2025half-yearfinancialrep.jpg GRAPHIC 277716
11 a2025half-yearfinancialrepa.jpg GRAPHIC 701024
  Complete submission text file 0001121404-25-000022.txt   15520818

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sny-20250630.xsd EX-101.SCH 190315
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sny-20250630_cal.xml EX-101.CAL 137309
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sny-20250630_def.xml EX-101.DEF 714305
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sny-20250630_lab.xml EX-101.LAB 1275830
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sny-20250630_pre.xml EX-101.PRE 944501
124 EXTRACTED XBRL INSTANCE DOCUMENT sny-20250630_htm.xml XML 2638386
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251170323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)